¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hearing loss, functional"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • functional antigen
    ±â´ÉÇ׿ø
  • functional aphasia
    ±â´É¼º¾ð¾î»ó½ÇÁõ, ±â´É¼º½Ç¾îÁõ
  • functional asplenia
    ±â´É¼ºÁö¶ó¾øÀ½(Áõ)
  • functional bleeding
    ±â´ÉÀûÃâÇ÷
  • functional blindness
    ±â´É½Ã°¢»ó½Ç
  • functional capacity
    ±â´É¿ë·®
  • functional cardiovascular disease
    ±â´É¼º½É(Àå)Ç÷°üº´
  • functional congestion
    ±â´É¿ïÇ÷
  • functional deafness
    ±â´É¼º³­Ã»
  • functional death
    ±â´ÉÀû»ç¸Á
  • functional disorder
    ±â´É¼ºÀå¾Ö
  • functional dyspepsia
    ±â´É¼º¼ÒÈ­ºÒ·®
  • functional endoscopic sinus surgery
    ±â´É³»½Ã°æÄÚ°ç±¼¼ö¼ú, ±â´É³»½Ã°æºÎºñµ¿¼ö¼ú
  • functional food
    ±â´É½Äǰ
  • functional genomics
    ±â´ÉÀ¯ÀüüÇÐ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • radiation loss
    ¹æ»ç¼±¼Õ½Ç
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • vitreous loss
    À¯¸®Ã¼Å»Ãâ
  • functional amblyopia
    ±â´ÉÀÌ»ó¾à½Ã
  • functional antigen
    ±â´ÉÇ׿ø
  • functional aphasia
    ±â´É¼º¾ð¾î»ó½ÇÁõ
  • functional asplenia
    ±â´ÉÁö¶ó¾øÀ½Áõ
  • functional residual air
    ±â´ÉÀûÀܱâ
  • functional bleeding
    ±â´ÉÃâÇ÷
  • functional blindness
    ±â´É½Ã°¢»ó½Ç, ±â´É»ö¸Í
  • functional metrorrhagia bleeding
    ±â´ÉÀÚ±ÃÃâÇ÷
  • functional capacity
    ±â´É¿ë·®
  • functional congestion
    ±â´É¿ïÇ÷
  • functional residual capacity
    ±â´ÉÀûÀܱâ¿ë·®
  • functional deafness
    ±â´É³­Ã»
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Functional hypoglycemia
    ±â´É¼º ÀúÇ÷´çÁõ(¡­î¸úìÓØñø)
  • Hearing
    û°¢(ôéÊÆ)
  • Hearing test
    û·ÂÅ×½ºÆ®
  • absolute hearing
    Àý´ëÀ½°¨
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • functional albuminuria
    ±â´É¼º ´Ü¹é´¢.
  • functional amblyopia
    ±â´É¾à½Ã
  • functional antigen
    ±â´É(Àû) Ç׿ø.
  • functional aphasia
    ±â´É¼º ½Ç¾î(Áõ).
  • functional aphasia See aphasia
    ±â´É¼º ½Ç¾î(Áõ)(ѦÒöàõã÷åÞñø)
  • functional aphonia
    ±â´É¼º ½Ç¼º(Áõ).
  • functional aphonia
    ±â´É(Àû) ½Ç¾îÁõ
  • functional aphonia See aphonia
    ±â´É¼º ½Ç¼º(Áõ)(ѦÒöàõã÷á¢ñø)
  • functional apoplexy
    ±â´É¼º Á¹Áß(¡­ðïñé).
  • functional asplenia
    ±â´ÉÀû ¹«ºñÁõ(¡­ÙíÞ¡ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç(¡­ôéæ³ áßã÷)
  • hearing amelioration =hearing improvement, hearin
    û·Â°³¼±
  • hearing distance =hearing range
    û·Â°Å¸®, °¡Ã»°Å¸®
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • functional albuminuria
    ±â´É¼º ´Ü¹é´¢.
  • functional amblyopia
    ±â´É¾à½Ã
  • functional antigen
    ±â´É(Àû) Ç׿ø.
  • functional aphasia
    ±â´É¼º ½Ç¾î(Áõ).
  • functional aphasia See aphasia
    ±â´É¼º ½Ç¾î(Áõ)(ѦÒöàõã÷åÞñø)
  • functional aphonia
    ±â´É(Àû) ½Ç¾îÁõ
  • functional aphonia
    ±â´É¼º ½Ç¼º(Áõ).
  • functional aphonia See aphonia
    ±â´É¼º ½Ç¼º(Áõ)(ѦÒöàõã÷á¢ñø)
  • functional apoplexy
    ±â´É¼º Á¹Áß(¡­ðïñé).
  • functional asplenia
    ±â´ÉÀû ¹«ºñÁõ(¡­ÙíÞ¡ñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FAI first aid instruction; free androgen index; functional aerobic impairment; functional assessment inv...
FRC Federal Radiation Council; frozen red cells; functional reserve capacity; functional residual capaci...
LOC Loss Of Consciousness
ABCDES abnormal alignment, bones-periarticular osteoporosis, cartilage-joint space loss, deformities, margi...
ABL abetalipoproteinemia; acceptable blood loss; African Burkitt lymphoma; Albright-Butler-Lightwood [sy...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
H.L. Hearing level
HTL Hearing threshold level
NH Normal-hearing
UNHS Universal newborn hearing screening
HA hearing aid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • weight loss
    üÁß °¨¼Ò
    ´Ü½Ä, ½ÄÀÌÁ¶Àý, º´À¸·Î ÀÎÇØ ³ªÅ¸³ª¸ç, üÁö¹æÀÇ °¨¼Ò ¶Ç´Â À½½Ä¼·Ãë ºÎÁ·À¸·Î ÀÎÇÑ ¿µ¾ç°áÇÌ ½Ã¿¡ ³ªÅ¸³­´Ù.
  • functional abnormality
    ±â´ÉÀû ÀÌ»ó
  • functional amblyopia
    ±â´É ¾à½Ã
  • functional aphasia
    ±â´É¼º ½Ç¾î
    È÷½ºÅ׸® ¶Ç´Â ÁßÁõ È÷½ºÅ׸®¼º Àå¾Ö¿¡ ±âÀÎÇÑ ½Ç¾îÁõ.
  • functional articulation
    ±â´É ±³ÇÕ
  • functional brain imaging
    ±â´ÉÀû ³ú ¿µ»ó
  • functional dead space
    ±â´ÉÀû »ç°­
  • functional disc dislocation
    °üÀý¿øÆÇÀÇ ±â´ÉÀû ÀüÀ§
  • functional disc displacement
    ±â´ÉÀû °üÀý¿øÆÇ º¯À§
  • functional dislocation with reduction
    Á¤º¹¼º ±â´ÉÀû ÀüÀ§
  • functional displacement
    ±â´ÉÀû º¯À§
  • functional endoscopic sinus surgery
    ±â´ÉÀû ³»½Ã°æ ºÎºñµ¿ ¼ö¼ú
  • functional force
    ±â´É·Â
  • functional jaw movement
    ±â´ÉÀû ÇÏ¾Ç ¿îµ¿
  • functional jaw orthopedic method
    ±â´ÉÀû ¾Ç±³Á¤¹ý
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
hair loss Hair loss may be associated with aging, hormones (androgens) or genetic predisposition. The pattern of baldness in women is different from that of men. In women there is thinning of the hair all over the scalp, but the frontal hairline is maintained. The hair loss is usually permanent. Treatment has been successful with topical minoxidil in some cases.
(13 Nov 1997)
drift cyclotron loss cone instabilities (DCLC) This is an electrostatic microinstability (frequencies at harmonics of the ion cyclotron frequency) which is of major concern in small mirror devices. Mode is driven by radial gradients in the electron density, and causes loss of ions due to non-conservation of magnetic moment (see adiabatic invariant) as they interact with the mode, and are dispersed in velocity space into the loss cone. Stabilisation is accomplished by increasing the plasma size and by partially filling the loss cone with a continuous extermal warm plasma stream.
(09 Oct 1997)
eddy-current loss <radiobiology> Energy loss due to eddy currents circulating in a resistive material.
(09 Oct 1997)
tooth loss The failure to retain teeth as a result of disease or injury.
(12 Dec 1998)
loss cone In a magnetic mirror machine, particles with a large velocity parallel to the magneitc field and a small velocity perpendicular to the field will be able to escape past the magnetic mirror (see magnetic mirror). In that case the velocity distribution function (see distribution function) will be almost zero in the region of velocity space that allows particles to escape. The shape of that region (in a velocity space diagram with parallel velocity and perpendicular velocity as the axes) is a cone. When a particle undergoes a collision, its velocity gets somewhat randomised. Particles that are scattered into that cone are lost very quickly (in one mirror bounce time). Thus it is called a loss cone. Because of the loss cone, the theoretical maximum particle confinement time of a magnetic mirror machine can be only a few times the particle collision time, this is generally seen as a showstopper for mirror-based fusion research.
(09 Oct 1997)
loss of consciousness Total unresponsiveness. An important neurologic sign.
(27 Sep 1997)
loss of heterozygosity Refers to a mutation that results in the loss of allelic uniqueness, which is often defined as a greater than or equal to 40 percent increase in signal intensity of allelic signal. Loss of heterozygosity is most frequently identified in certain chromosome regions, including 5q, 17p, and 18q.
(12 Dec 1998)
orthodontic appliances, functional Loose, usually removable intra-oral devices which alter the muscle forces against the teeth and craniofacial skeleton. These are dynamic appliances which depend on altered neuromuscular action to effect bony growth and occlusal development. They are usually used in mixed dentition to treat paediatric malocclusions. (ada, 1992)
(12 Dec 1998)
functional 1. Pertaining to, or connected with, a function or duty; official.
2. <physiology> Pertaining to the function of an organ or part, or to the functions in general.
<medicine> Functional disease, a disease of which the symptoms cannot be referred to any appreciable lesion or change of structure; the derangement of an organ arising from a cause, often unknown, external to itself opposed to organic disease, in which the organ itself is affected.
Source: Websters Dictionary
(01 Mar 1998)
functional albuminuria A collective term denoting types of benign albuminuria that are associated with physical exertion or other conditions in which there are physiologic changes such as during pregnancy or adolescence.
Synonym: physiologic albuminuria.
(05 Mar 2000)
functional anatomy Anatomy studied in its relation to function.
Synonym: morphophysiology, physiological anatomy.
(05 Mar 2000)
functional aphasia Nonorganic aphasia related to conversion hysteria.
(05 Mar 2000)
functional apoplexy A condition simulating apoplexy without any cerebral lesion; a form of conversion hysteria.
(05 Mar 2000)
functional blindness Apparent loss of vision related to suggestibility.
(05 Mar 2000)
functional cardiovascular disease A euphemism for cardiovascular symptoms deemed to be psychogenic. More generally, sometimes used for abnormal cardiac function.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á